John Andrew Dawson - 18 Oct 2026 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Reporting relationship: Director
Issuer ticker: PDSB
Reported as of: 18 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Oct 2026, 18:41:51 UTC
Source filing: View source filing
Reporting owner signature: /s/ John Andrew Dawson

Filing notes and source

Key filing fact

John Andrew Dawson filed Form 4 for PDS Biotechnology Corp (PDSB) on 21 Oct 2026.

Key facts

This page summarizes John Andrew Dawson's Form 4 filing for PDS Biotechnology Corp (PDSB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Oct 2026, 18:41.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002161463 Primary reporting owner

Dawson John Andrew

Relationship: Director
Address: C/O PDS BIOTECHNOLOGY CORPORATION, 303A COLLEGE ROAD EAST, PRINCETON
Signature: /s/ John Andrew Dawson
Signature date: 21 Oct 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PDSB transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +22,700
Change %
Price: $0.000000^*
Shares after: 22,700
Date: 18 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,700
Exercise price: $1.13
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Stock Option shall vest in three (3) equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such dates.